期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
CARIDIAC TRANSPLANTATION IN PATIENTS OVER 60 YEARS OLD
1
作者 陈长志 陆佩中 《Medical Bulletin of Shanghai Jiaotong University》 CAS 2000年第2期120-123,共4页
ffeSUm6 Objectif Pour dvaluer la limite d' age de transplantation cordiaque en sc agent sur l' analyse des rdsultats dlong tease des ma lades Othe. at~ L' etude s' est faite mr 161 oas de transPlantati... ffeSUm6 Objectif Pour dvaluer la limite d' age de transplantation cordiaque en sc agent sur l' analyse des rdsultats dlong tease des ma lades Othe. at~ L' etude s' est faite mr 161 oas de transPlantation cardiaque de l' octobre 1984 an~bre 1996 a l' H6Pital Hartford. De a divisd ies malndes en deux grouch: grouch senile (n = 35 ) aunt l' age moyen 63, 5f 2, 7(60 -- 68) et grouch t&moin (n = 126 ) avec l' age mopn 47, 6 1 11, 3. ho cardiopethies en cause pour la transplantation cardiaque des deux poupe de ma... 展开更多
关键词 heart transplantation elderly survival rate quality of life
下载PDF
Oncothermia in Combination with Vitamin C Infusion for Non-small Cell Lung Cancer: a Case Report
2
作者 Jun Wen Ou Yi Min Lu +1 位作者 Xin Yu Zhu Clifford L.K.Pang 《Journal of Nutritional Oncology》 2019年第3期146-150,共5页
We herein report an advanced case(T3N3M0,Stage ⅢB)of squamous cell lung cancer.The patient survived beyond 5 years only receiving intravenous vitamin C(VitC)infusion combined with modulated electrohyperthermia(mEHT,t... We herein report an advanced case(T3N3M0,Stage ⅢB)of squamous cell lung cancer.The patient survived beyond 5 years only receiving intravenous vitamin C(VitC)infusion combined with modulated electrohyperthermia(mEHT,trade name:oncothermia). 展开更多
关键词 Modulated electrohyperthermia High-dose vitamin C Advanced NSCLC survival time quality of life
下载PDF
Clinical Study on Effect of Kang'aibao Oral Liquid(抗癌宝口服液) in Treating 103 Patients of Malignant Tumor
3
作者 王怀璋 林焯唐 《Chinese Journal of Integrative Medicine》 SCIE CAS 1999年第4期261-264,共4页
Objective: To observe the clinical efficacy of Kang'aibao oral liquid (KABL), a Chinese herbal preparation in treating malignant tumor of middle or advanced stage. Methods: A comparative study was done by observin... Objective: To observe the clinical efficacy of Kang'aibao oral liquid (KABL), a Chinese herbal preparation in treating malignant tumor of middle or advanced stage. Methods: A comparative study was done by observing the effect of 103 patients treated with KABL, and another 90 patients treated with chemotherapy at the same time were taken as the control group.Results: The immunologic function, short term effective rate (complete relieved rate and partial relieved rate), survival quality, 1 , 2 and 3 year survival rate, median survival time, and carcinoembryonic antigen (CEA) declining rate of the KABL group were significantly higher than those of the control group. Conclusion: KABL has the effects of inhibiting tumor growth, prolonging survival time and improving survival quality of tumor patients. 展开更多
关键词 malignant tumor of middle or advanced stage Kang'aibao oral liquid survival time survival quality
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部